EUVIMEDEUVIMED entdecken
Crossref

Advanced Ovarian Cancer: Assessing the Role of Cytoreductive Surgery and HIPEC

Chiranjit Mukherjee, Somdeep Ghosh, Suman Singh

International Journal of Pharmaceutical Quality Assurance · 11.07.2026 · 16 (12)

DOI: 10.25258/ijpqa.16.12.139 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Pharmaceutical Quality Assurance, online erschienen am 11.07.2026. Verfasst von Chiranjit Mukherjee und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

.

Zitieren

APA

Mukherjee, C., Ghosh, S., & Singh, S. (2026). Advanced Ovarian Cancer: Assessing the Role of Cytoreductive Surgery and HIPEC. International Journal of Pharmaceutical Quality Assurance, 16(12). https://doi.org/10.25258/ijpqa.16.12.139

Vancouver

Mukherjee C, Ghosh S, Singh S. Advanced Ovarian Cancer: Assessing the Role of Cytoreductive Surgery and HIPEC. International Journal of Pharmaceutical Quality Assurance. 2026;16(12). doi:10.25258/ijpqa.16.12.139

BibTeX
@article{Mukherjee2026,
  author = {Mukherjee, Chiranjit and Ghosh, Somdeep and Singh, Suman},
  title = {Advanced Ovarian Cancer: Assessing the Role of Cytoreductive Surgery and HIPEC},
  journal = {International Journal of Pharmaceutical Quality Assurance},
  year = {2026},
  volume = {16},
  number = {12},
  doi = {10.25258/ijpqa.16.12.139}
}
Kostenlos starten →